Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats

American Journal of Nephrology

Volumn 29, Issue 6, 2009, Pages 639-645

  Susic, Dinko ^a   Zhou, Xiaoyan ^a   Frohlich, Edward D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Glomerular filtration rate; Hypertension; Proteinuria; Renal blood flow; Renin angiotensin system; Salt excess

Indexed keywords

CANDESARTAN; LOSARTAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HISTOPATHOLOGY; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY MASS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SALT OVERLOAD;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; BENZIMIDAZOLES; BODY WEIGHT; HEART VENTRICLES; HEMODYNAMICS; HYPERTENSION; KIDNEY; LOSARTAN; MALE; ORGAN SIZE; RATS; RATS, INBRED SHR; RENAL CIRCULATION; RENAL INSUFFICIENCY; SODIUM CHLORIDE, DIETARY; TETRAZOLES;

EID: 58249125152     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000195633     Document Type: Article

References (39)

1. Elliot P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M: Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations: Intersalt Cooperative Research Group. BMJ 1996;312:1249-1253.
2. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA: Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE): TONE Collaborative Research Group. JAMA 1988;279:839-846.
3. duCailar G, Ribstein J, Mimran A: Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002;15:222-229.
4. Leenen FH, Yuan B: Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 1998;16:885-892.
5. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A: Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357: 848-851.
6. Yu HCM, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998;98:2621-2628.
7. Frohlich ED, Chien Y, Sesoko S, Pegram B: Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WK Y rats. Am J Physiol 1993;264: R30-R34.
8. Ahn J, Varagic J, Slama M, Susic D, Frohlich ED: Cardiac structural and functional responses to salt loading in SHR. Am J Physiol 2004;287:H767-H772.
9. Varagic J, Frohlich ED, Díez J, Susic D, Ahn J, González A, López B: Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol 2006;290:H1503-H1509.
10. Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED: Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol 2007;292:H814-H819.
11. Endemann DH, Toyuz R M, Iglarez M, Savoia C, Schiffrin EL: Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in spontaneously hypertensive rats. Hypertension 2004;43:1252-1257.
12. Bayorh MA, Mann G, Walton M, Eatman D: Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl saltsensitive rats. Clin Exp Hypertens 2006;28: 121-132.
13. Maitland K, Bridges L, Davis WP, Loscalzo J, Pointer MA: Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension. Circulation 2006;114: 905-991.
14. Inada Y, Tazawa S, Murakami M, Akahane M: KRH-594, a new angiotensin AT1 receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hyperten-sive/Izm rats. Clin Exp Pharmacol Physiol 2001;28:206-211.
15. Kreutz R, Fernandez-Alfonso MS, Liu Y, Ganten D, Paul M: Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med 1995;73: 243-248.
16. Strier CT Jr, Chander P, Gutstein WH, Levine S, Itskovitz HD: Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hyportensive effect. Am J Hypertens 1991;3: 680-687.
17. Frohlich ED, Varagic J: The role of sodium in hypertension is more complex than simply elevating arterial pressure. Nat Clin Pract Cardiovasc Med 2004;1:24-30.
18. Frohlich ED: The salt conundrum. A hypot hesis. Hypertension 2007;50:61-66.
19. Ono H, Ono Y, Frohlich ED: ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension 1966;27: 176-183.
20. Zhou X, Ono H, Matavelli L, Frohlich ED: Superiority of combination of thiazide with angiotensin converting enzyme inhibitor or AT1 receptor blocker over thiazide alone in renoprotection of l-NAME spontaneously hypertensive rats. Am J Physiol 2005;289: F871-F879.
21. Zhou X, Ono H, Ono Y, Frohlich ED: Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in l -NAME/SHR model. Am J Nephrol 2004;24: 242-249.
22. Susic D, Nunez E, Hosoya K, Frohlich ED: Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hypertens 1998;16:231-237.
23. Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, López B, Díez J: AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol 2008;294:H853-H858.
24. Teräväinen TL, Mervaala EM, Pörsti I, Laakso J, Vapaatalo H, Karppanen H: Inf luence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats. Methods Find Exp Clin Pharmacol 1997;9:311-321.
25. Wyss JM, Roysommuti S, King K, Kadisha I, Regan CP, Berecek KH: Salt-induced hypertension in normotensive and spontaneously hypertensive rats. Hypertension 1994;23: 791-796.
26. Mercier N, Labat C, Louis H, Cattan V, Benetos A, Safar ME, Lacolley P: Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens 2007;20: 319-325.
27. Fang Z, Sripairojthikoon W, Calhoun DA, Zhu S, Berecek KH, Wyss JM: Interaction between lifetime captopril treatment and NaCl-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertens 1999;17:983-991.
28. Otani L, Yasumatsu T, Murakami M, Hayashi A, Kimoto K, Murakami T: Reduction of salt sensitivity in stroke-prone spontaneously hypertensive rats administered an AT1 receptor antagonist during suckling. Am J Hypertens 2006;19:979-984.
29. 1 receptor overexpression in vitro and in vivo. Hypertension 1988;31:1272-1277.
30. Varagic J: Salt-loading: a paradigm for a local cardiac renin-angiotensin-aldosterone system;in Frohlich ED, Re RN (eds): The Local Cardiac Renin Angiotensin-Aldosterone System. New York, Springer Science and Business Media, 2006, pp 61-72.
31. Williams JS, Solomon SD, Crivaro M, Conlin PR: Dietary sodium intake modulates myocardium relaxation responsiveness to angiotensin II. Transl Res 2006;148:49-54.
32. Navar LG, Prieto-Carrasquero MC, Kobori H: Regulation of renin in JGA and tubules in hypertension;in Frohlich ED, Re RN (eds): The Local Cardiac Renin Angiotensin-Aldo-sterone System. New York, Springer Science and Business Media, 2006, pp 45-59.
33. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ: Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol Endocrinol Metab 1992;263:E863-E869.
34. Thomson SC, Deng A, Wead L, Richter K, Blantz RC, Vallon V: An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J Clin Invest 2006;116:1110 -1116.
35. Cordaillat M, Rugale C, Casellas D, Mimran A, Jover B: Cardiorenal abnormalities associated with high sodium intake: correction by spironolactone in rats. Am J Physiol Reg -ul Integr Comp Physiol 2005;289:R1137-R1143.
36. Sanders PW: Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hy pertens 2006;15:54-60.
37. Laffer CL, Bolterman RJ, Romero JC, Elijovich F: Effect of salt on isoprostanes in saltsensitive essential hypertension. Hypertension 2006;47: 434-440.
38. Beck JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB: Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol Renal Physiol 1988;274:F914-F923.
39. Khalil RA: Dietary salt and hypertension: new molecular targets add more spice. Am J Physiol Regul Integr Comp Physiol 2006;290:R509-R513.